Royalty Pharma Plc (RPRX)
61.33
+0.02
(+0.03%)
USD |
NASDAQ |
Aug 24, 16:00
61.32
-0.01
(-0.02%)
After-Hours: 20:00
Royalty Pharma Total Assets (Quarterly) : 19.82B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.82B |
| March 31, 2026 | 19.82B |
| December 31, 2025 | 19.62B |
| September 30, 2025 | 19.35B |
| June 30, 2025 | 18.32B |
| March 31, 2025 | 17.61B |
| December 31, 2024 | 18.22B |
| September 30, 2024 | 18.04B |
| June 30, 2024 | 17.66B |
| March 31, 2024 | 16.13B |
| December 31, 2023 | 16.38B |
| September 30, 2023 | 15.86B |
| June 30, 2023 | 17.12B |
| March 31, 2023 | 17.07B |
| Date | Value |
|---|---|
| December 31, 2022 | 16.81B |
| September 30, 2022 | 17.67B |
| June 30, 2022 | 17.74B |
| March 31, 2022 | 17.38B |
| December 31, 2021 | 17.52B |
| September 30, 2021 | 17.73B |
| June 30, 2021 | 16.51B |
| March 31, 2021 | 15.91B |
| December 31, 2020 | 16.02B |
| September 30, 2020 | 15.99B |
| June 30, 2020 | 15.69B |
| March 31, 2020 | 13.37B |
| December 31, 2019 | 12.45B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 114.02B |
| Johnson & Johnson | 201.06B |
| Viatris, Inc. | 35.04B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.03B |
| Shareholders Equity (Quarterly) | 6.833B |
| Debt to Equity Ratio | 1.312 |
| Current Ratio | 2.797 |
| Net Debt Paydown Yield | -1.08% |